Skip to main content

Researchers test using AI to optimize IVF embryo selection

A new AI approach by Weill Cornell Medicine investigators can accurately identify whether a 5-day-old, IVF human embryo has high potential to progress to a successful pregnancy.

Ahmed Ahmed ’17 wins Soros Fellowship for New Americans

Ahmed Ahmed ’17, whose remarkable journey led him from a Kenyan refugee camp to Cornell, has been awarded a Paul and Daisy Soros Fellowship for New Americans, which will support his medical school studies.

Barrett: Food security is ‘challenge of the century’

Cornell professor Chris Barrett gave the 15th annual George McGovern Lecture April 4 at the Food and Agriculture Organization of the United Nations in Rome.

Cornell Center for Health Equity symposium to bridge NYC – Ithaca research

The Cornell Center for Health Equity will hold its second annual symposium April 11-12 at Cornell’s College of Veterinary Medicine on the Ithaca campus.

Researchers discover treatment target for people with IBD

People with inflammatory bowel disease and food allergies are one step closer to a possible treatment, thanks to researchers at Weill Cornell Medicine.

Starr Foundation extends NYC stem cell research support with $50M gift

The Starr Foundation is continuing its commitment to stem cell research with a $50 million gift supporting the Tri-Institutional Stem Cell Initiative, a collaboration involving Weill Cornell Medicine.

NIH immunologist wins Drukier Prize in Children’s Health Research

Clinical immunologist Dr. Helen Su, who studies the genetic causes of rare immune system diseases in children, has been awarded the Drukier Prize in Children’s Health Research by Weill Cornell Medicine.

Gene variant may affect breast cancer survival for black women

A set of gene variants originating in Sub-Saharan West Africa may help explain why black women have worse breast cancer outcomes than white women, say researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Nanovaccine boosts immunity in sufferers of metabolic syndrome

A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria – a population that shows resistance to traditional flu and polio vaccine.